Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Commercial rights of the ATX-101. The asset includes all rights outside of the U.S. and Canada to ATX-101, a proprietary formulation of a purified synthetic version of deoxycholic acid currently in late-stage development for the reduction of submental fat.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Primary Office
  • 51368 Leverkusen
  • Germany

Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)‘s full profile, request access.

Request full access to PitchBook

Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bayer Consumer Care (Rights to ATX-101 Outside of the US and Canada)‘s full profile, request access.

Request full access to PitchBook